Bossini A, Di Veroli C
Servizio per l'Ipertensione Arteriosa e le Nefropatie, Policlinico Umberto I, Roma.
Riv Eur Sci Med Farmacol. 1990 Apr;12(2):91-8.
The effects of a 12-week treatment with acebutolol on serum lipids have been studied in 18 patients. Acebutolol was given as a 400-, 600-, or 800-mg single daily dose in the morning. Standing and supine blood pressure diminished significantly, whereas the major indexes of lipid metabolism such as total serum cholesterol, HDL-cholesterol, triglycerides, and plasma lipoproteins were not significantly affected. The treatment was well tolerated.
